## ITW: Illinois Tool Works Inc. - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 3.8% below STRENGTH zone (4.0-10.0%); PEG 3.56 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($249.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Does Insider Buying And Record Margins Change The Bull Case For Illinois Tool Works (ITW)?**
- Source: Simply Wall Street | 20251215T183812 | Somewhat-Bullish | Relevance: 100%
- Illinois Tool Works director David Byron Smith recently purchased shares, coinciding with the company reporting record operating margins of 27.4% and strong cash generation, supported by its Enterprise Initiatives program. These events, along with reaffirmed GAAP EPS guidance, indicate management's confidence in sustaining profitability despite market challenges. The article explores how this insider buying and profitability may impact the investment narrative for ITW, noting mixed institutional sentiment and segment headwinds.

**2. Illinois Tool Works (ITW): Valuation Check After Insider Buying, Record Margins and Brighter Earnings Outlook**
- Source: Simply Wall Street | 20251214T150823 | Bullish | Relevance: 100%
- Illinois Tool Works (ITW) is gaining investor attention after an insider bought shares, coinciding with the company reporting record operating margins and strong cash generation. The stock is currently deemed 1.1% undervalued by analysts, with a consensus price target slightly above its last close. While the company exhibits steady growth and resilient margins, execution remains key due to potential pressures in automotive and construction segments.

**3. Caxton Associates LLP Raises Stake in Illinois Tool Works Inc. $ITW**
- Source: MarketBeat | 20251214T100828 | Neutral | Relevance: 100%
- Caxton Associates LLP significantly increased its stake in Illinois Tool Works (NYSE:ITW) by 105.4% during the second quarter, bringing its total holdings to 16,118 shares valued at approximately $3.99 million. This surge in institutional investment comes despite analysts downgrading ITW to a "Reduce" rating with an average target price of $261.58. The company recently exceeded EPS estimates, announced its FY2025 guidance, and declared a quarterly dividend of $1.61 per share.

**4. Illinois Tool Works Inc. $ITW Shares Sold by Gamco Investors INC. ET AL**
- Source: MarketBeat | 20251212T100748 | Neutral | Relevance: 100%
- Gamco Investors INC. ET AL significantly reduced its stake in Illinois Tool Works Inc. ($ITW) by 59% in Q2, selling 7,020 shares and retaining 4,880 shares valued at approximately $1.21 million. Despite Institutional investors owning nearly 80% of the stock, analyst sentiment is mixed, with a consensus "Reduce" rating and a target price of $261.58. Illinois Tool Works recently beat EPS estimates, provided positive FY2025 guidance, and declared a quarterly dividend of $1.61.

**5. Dearborn Partners LLC Sells 26,535 Shares of Illinois Tool Works Inc. $ITW**
- Source: MarketBeat | 20251212T000830 | Somewhat-Bearish | Relevance: 100%
- Dearborn Partners LLC reduced its stake in Illinois Tool Works Inc. (NYSE:ITW) by 15% in Q2, selling 26,535 shares. Despite the sell-off, Illinois Tool Works remains a significant holding for Dearborn Partners and reported strong quarterly EPS, beating expectations, and issued positive FY2025 guidance. However, analyst sentiment for ITW is cautious, with a consensus "Reduce" rating and an average price target of $261.58.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-18 | B of A Securiti | $255 | $220 | +16% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-18 | B of A Securiti | up | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($0.11M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.8% |
| Smart Money | **NEUTRAL** |
| Net Flow | 0.0% |
| Buying/Selling | 2 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (-0.1%)
- Briar Hall Managemen: 8.9% (0.0%)
- State Farm Mutual Au: 7.2% (0.0%)
- Blackrock Inc.: 7.2% (-3.6%)
- State Street Corpora: 4.3% (-0.2%)

### Key Risks

1. Valuation stretched: PEG 3.6x requires aggressive growth execution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +4.9% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 3.56 signals overvaluation risk, limited margin of safety. Forward P/E 22.8x stretched relative to 8% growth. Quality metrics strong (ROE 92%, ROA 16%, margin 19%). Analyst sentiment positive (1 raises, avg +16%).

| Metric | Value |
|--------|-------|
| Market Cap | $75.2B |
| Beta | 1.15 |
| 52W Range | $214.66 - $278.13 |
| Short Interest | 2.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.56 |
| Forward P/E | 22.8 |
| Current P/E | 24.7 |
| YoY Growth | 8.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from -1.2% to 3.8% (+4.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 0.2pp (needs >4.0% for momentum thesis). MRS_5 at 3.5% confirms short-term momentum alignment. AM_20 at 4.1% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.34), confirming momentum. OFD pattern: -SLN (Support test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.75% (CS: 67) | Neutral |
| RSI_14 | 66.0 | Neutral |
| MACD Histogram | 1.34 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.040x | Above |
| vs SMA200 | 1.027x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $258.02
- **Stop Loss:** $249.82 (3.2% risk)
- **Target:** $266.22 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 146
- **Position Value:** $37,670.92
- **Portfolio %:** 37.67%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX remains calm at 15.74 while breadth shows modest participation at 54%, suggesting selective positioning. FOMC meeting in 4 days creates near-term uncertainty but no systemic stress evident.*

### Earnings

**Next:** 2026-02-04 (Est: $2.69)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.70 | $2.81 | +4.0% |
| 2025Q2 | $2.57 | $2.58 | +0.5% |
| 2025Q1 | $2.35 | $2.38 | +1.1% |
| 2024Q4 | $2.49 | $2.54 | +1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*